26 May 2013
Keywords: fda, calls, data, immuneregen, homspera, during, recent
Article | 05 April 2004
During a recent meeting with the US Food and Drug Administration's Division of Counter-Terrorism, ImmuneRegen was requested to conduct an
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 April 2004
29 March 2004
24 May 2013
© 2013 thepharmaletter.com